简介：
Overview
This article presents a protocol for a nicotinamide adenine dinucleotide (NADH)-coupled ATPase assay optimized for semi-high-throughput screening of small molecule myosin inhibitors. The assay is designed to be run in a 384-well microplate format, making it suitable for various ADP-producing enzymes.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Pharmacology
Background
- The assay is applicable to developing ATPase inhibitors.
- It serves as a probe for basic research and potential clinical compounds.
- The method avoids common artifacts and does not involve hazardous materials.
- Specific inhibitors for non-muscle myosin II are being developed for treating methamphetamine use disorder.
Purpose of Study
- To provide a reliable screening method for ATPase inhibitors.
- To facilitate research into non-muscle myosin II inhibitors.
- To optimize the assay for semi-high-throughput applications.
Methods Used
- NADH-coupled ATPase assay.
- 384-well microplate format.
- 20 µL total reaction volumes per well.
- Visual demonstrations to clarify technical details.
Main Results
- Successful adaptation of the assay for screening small molecule inhibitors.
- Demonstrated applicability to various ADP-producing enzymes.
- Potential for developing specific inhibitors for clinical use.
- Minimized handling of hazardous materials during the process.
Conclusions
- The optimized assay is effective for semi-high-throughput screening.
- It can be applied to a wide range of ATP-producing enzymes.
- Further research may lead to new therapeutic options for methamphetamine use disorder.
What is the main application of this assay?
The assay is primarily used for screening ATPase inhibitors, particularly for non-muscle myosin II.
How does this method avoid common artifacts?
The method has been optimized to minimize artifacts and does not require hazardous materials.
What is the significance of using a 384-well format?
The 384-well format allows for semi-high-throughput screening, increasing efficiency in testing multiple compounds.
Can this assay be used for other enzymes?
Yes, it can be applied to any enzymes that produce ATP.
What are the potential clinical implications of this research?
The research aims to develop specific inhibitors that could be used in treating methamphetamine use disorder.
Is visual demonstration included in the protocol?
Yes, visual demonstrations are provided to clarify important technical details.
繁體中文
